Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: Insights from the Food and Drug Administration 2019 Circulatory System Devices Panel Meeting on late mortality.
Dan K, Shlofmitz E, Khalid N, Hideo-Kajita A, Wermers JP, Torguson R, Kolm P, Garcia-Garcia HM, Waksman R. Dan K, et al. Among authors: hideo kajita a. Am Heart J. 2020 Apr;222:112-120. doi: 10.1016/j.ahj.2019.12.012. Epub 2019 Dec 28. Am Heart J. 2020. PMID: 32028137 Review.
Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: an optical coherence tomography analysis.
Ozaki Y, Garcia-Garcia HM, Hideo-Kajita A, Kuku KO, Haude M, Ince H, Abizaid A, Tölg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Escaned J, Dijkstra J, Waksman R. Ozaki Y, et al. Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):916-924. doi: 10.1093/ehjci/jey210. Eur Heart J Cardiovasc Imaging. 2019. PMID: 30590578 Clinical Trial.
Serial 3-Dimensional Optical Coherence Tomography Assessment of Jailed Side-Branch by Second-Generation Drug-Eluting Absorbable Metal Scaffold (from the BIOSOLVE-II Trial).
Ozaki Y, Garcia-Garcia HM, Hideo-Kajita A, Kuku KO, Haude M, Ince H, Abizaid A, Tölg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Escaned J, Waksman R. Ozaki Y, et al. Am J Cardiol. 2019 Apr 1;123(7):1044-1051. doi: 10.1016/j.amjcard.2018.12.029. Epub 2019 Jan 4. Am J Cardiol. 2019. PMID: 30683424 Clinical Trial.
Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention.
Hideo-Kajita A, Rogers T, Buchanan K, Iantorno M, Gajanana D, Ozaki Y, Dan K, Kolm P, Brathwaite E, Beyene S, Melaku G, Meirovich Y, Dheendsa A, Garcia-Garcia HM, Torguson R, Waksman R. Hideo-Kajita A, et al. Am J Cardiol. 2019 Apr 15;123(8):1228-1238. doi: 10.1016/j.amjcard.2019.01.031. Epub 2019 Jan 25. Am J Cardiol. 2019. PMID: 30738570
Coronary Artery Disease Assessed by Computed Tomography-Based Leaman Score in Patients With Low-Risk Transcatheter Aortic Valve Implantation.
Ozaki Y, Garcia-Garcia HM, Rogers T, Torguson R, Craig PE, Hideo-Kajita A, Gordon P, Ehsan A, Parikh P, Bilfinger T, Butzel D, Buchanan S, Levitt R, Hahn C, Buchbinder M, Hanna N, Garrett R, Wilson SR, Goncalves JA, Ali S, Asch FM, Weissman G, Shults C, Ben-Dor I, Satler LF, Waksman R. Ozaki Y, et al. Among authors: hideo kajita a. Am J Cardiol. 2020 Apr 15;125(8):1216-1221. doi: 10.1016/j.amjcard.2020.01.022. Epub 2020 Jan 28. Am J Cardiol. 2020. PMID: 32087995
ANTARCTIC: platelet function testing to adjust therapy.
Hideo-Kajita A, Waksman R, Garcia-Garcia HM. Hideo-Kajita A, et al. Lancet. 2017 Mar 25;389(10075):1192-1193. doi: 10.1016/S0140-6736(17)30779-1. Lancet. 2017. PMID: 28353440 No abstract available.
36 results